Statins and glycaemic control in type 2 diabetes: Are bile acids relevant?

Simple item page
dc.contributor.authorSansome, D.J.
dc.contributor.authorJones, K.L.
dc.contributor.authorHorowitz, M.
dc.contributor.authorRayner, C.K.
dc.contributor.authorWu, T.
dc.date.issued2020
dc.descriptionLetter to the Editor
dc.description.abstractAbstract unavailable
dc.description.statementofresponsibilityDaniel J. Sansome, Karen L. Jones, Michael Horowitz, Christopher K. Rayner, Tongzhi Wu
dc.identifier.citationBritish Journal of Clinical Pharmacology, 2020; 86(12):2538-2539
dc.identifier.doi10.1111/bcp.14274
dc.identifier.issn0306-5251
dc.identifier.issn1365-2125
dc.identifier.orcidSansome, D.J. [0000-0002-5618-9602]
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]
dc.identifier.orcidWu, T. [0000-0003-1656-9210]
dc.identifier.urihttps://hdl.handle.net/2440/145913
dc.language.isoen
dc.publisherWiley
dc.rights© 2020 The British Pharmacological Society
dc.source.urihttps://doi.org/10.1111/bcp.14274
dc.subjectLetter to editor; statins; insulin resistance; type 2 diabetes (T2D); increase risk
dc.subject.meshHumans
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshBile Acids and Salts
dc.subject.meshBlood Glucose
dc.subject.meshHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subject.meshGlycemic Control
dc.titleStatins and glycaemic control in type 2 diabetes: Are bile acids relevant?
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Research Outputs